El habla de personas con enfermedad de Parkinson tras una neurocirugía: seguimiento de pacientes hispanohablantes en Bogotá durante un año

Vista sencilla de ítem
dc.contributor.advisorCamargo Mendoza, Maryluz
dc.contributor.advisorBernal Pacheco, Oscar
dc.contributor.authorCastillo Triana, Nicolás
dc.contributor.orcid0000-0003-0770-293Xspa
dc.contributor.researchgroupVoz, Habla y Degluciónspa
dc.contributor.scopus57196298692spa
dc.date.accessioned2022-11-28T22:16:36Z
dc.date.available2022-11-28T22:16:36Z
dc.date.issued2022
dc.descriptionilustraciones, gráficasspa
dc.description.abstractSe describieron las características del habla de un grupo de hispanohablantes con enfermedad de Parkinson (EP) que fueron tratados con estimulación cerebral profunda del núcleo subtalámico (STN-DBS). Se efectuó un estudio longitudinal con medidas PRE y POST implantación de la STN-DBS en 9 participantes con EP idiopática (4 mujeres y 5 hombres). Por cada participante se evaluó el deterioro del habla al inicio y al final del seguimiento y se tomaron medidas acústicas de la voz (f0, SDf0, intensidad, Jitter, RAP, Shimmer, NHR, HNR, LTAS y CPPs), tiempo máximo de fonación (TMF), de inteligibilidad del habla (% de palabras correctamente identificadas y grado de inteligibilidad), de velocidad del habla y de diadococinesia oral, antes de recibir la STN-DBS y cada 3 meses post intervención durante 1 año. Aunque no se encontraron cambios grupales POST que fueran estadísticamente significativos en ninguno de los parámetros de habla estudiados, ni un patrón de cambio identificable a lo largo del tiempo, un análisis de frecuencia de cambios POST intervención, así como de cambios individuales sostenidos en dos o más momentos de seguimiento POST constató cómo el efecto de la STN-DBS no fue el mismo para el habla de todos los participantes. Los datos muestran que estas diferencias podrían radicar en el sexo, el nivel de disartria PRE intervención, el estado de la medicación y los niveles de ciertos parámetros de estimulación cerebral, pues relacionadas con todas estas variables se evidenciaron cambios en el habla. Este es el primer estudio de su tipo en hispanohablantes y sus hallazgos garantizan investigación futura. (Texto tomado de la fuente)spa
dc.description.abstractThe aim of this study was to describe the speech characteristics of a sample of Spanish-speaking Parkinson´s disease (PD) patients treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS). A follow-up study of PRE and POST treatment onset speech measures was carried out on nine idiopathic PD patients who underwent STN-DBS surgery (4 females and 5 males). The severity of dysarthria of every patient was assessed at the beginning and the end of the follow-up, acoustic measures of voice (fo, SDfo, intensity, Jitter, RAP, Shimmer, NHR, HNR, LTAS y CPPs), Maximum Phonation Time (MPT), measures of intelligibility of speech (grade of intelligibility and percentage of correctly identified words), speech rate, and oral diadochokinesia were calculated before surgery and every 3 months post-surgery during one year. Although statistical significative post-surgery group changes in any speech measure, or a recognizable pattern of speech change during follow-up were not found, an analysis of frequency of POST surgery and of sustained POST surgery changes revealed that STN-DBS influences speech in a different way depending on the speech measure, sex, medication status, pre-surgery level of dysarthria and stimulation parameters levels, all of which were found related with speech parameters variations in some way. Currently, all of the research in this field is from non-Spanish-speaking PD patients an all of the findings of this study warrant further research.eng
dc.description.degreelevelMaestríaspa
dc.description.degreenameMagíster en Neurocienciasspa
dc.description.methodsSeguimiento longitudinal; serie de casos.spa
dc.format.extent288 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/82815
dc.language.isospaspa
dc.publisherUniversidad Nacional de Colombiaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.placeBogotá, Colombiaspa
dc.publisher.programBogotá - Medicina - Maestría en Neurocienciasspa
dc.relation.referencesAbeyesekera, A., Adams, S., Mancinelli, C., Knowles, T., Gilmore, G., Delrobaei, M., y Jog, M. (2019). Effects of Deep Brain Stimulation of the Subthalamic Nucleus Settings on Voice Quality, Intensity, and Prosody in Parkinson’s Disease: Preliminary Evidence for Speech Optimization. Canadian Journal of Neurological Sciences, 46(3), 287-294. doi: 10.1017/cjn.2019.16spa
dc.relation.referencesAhlberg, E., Laakso, K., y Hartelius, L. (2011). Perceived Changes in Communication as an Effect of STN Surgery in Parkinson’s Disease: A Qualitative Interview Study. Parkinson´s Disease, 2011, 540158. doi: 1 0.4061/2011/540158spa
dc.relation.referencesAldridge, D., Theodoros, D., Angwin, A., y Vogel, A. (2016). Speech outcomes in Parkinson`s disease after subthalamic nucleus deep brain stimulation: a systematic review. Parkinsonism and Related Disorders, 33, 3-11. doi: 10.1016/j.parkreldis.2016.09.022spa
dc.relation.referencesAnand, S., y Stepp, C. E. (2015). Listener perception of monopitch, naturalness, and intelligibility for speakers with Parkinson's disease. Journal of Speech, Language and Hearing Research, 58(4), 1134-1144. doi: 10.1044/2015_JSLHR-S-14-0243spa
dc.relation.referencesArgyropoulos, G. P. (Ed.). (2020). Translational Neuroscience of Speech and Language Disorders. Suiza: Springer Nature.spa
dc.relation.referencesArmstrong, M, y Okun, M. (2020). Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 323(6), 548-560. doi: 10.1001/jama.2019.22360spa
dc.relation.referencesArtusi, C. A., Lopiano, L., y Morgante, F. (2020). Deep brain stimulation selection criteria for Parkinson´s disease: time to go beyond CAPSIT-PD. Journal of Clinical Medicine, 9(12), 3931. doi: 10.3390/jcm9123931spa
dc.relation.referencesAviles-Olmos, Kefalopoulou, Z., Tripoliti, E., Candelario J., Akram, H., Martínez-Torres, I., … Limousin, P. (2014). Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease using an MRI-guided and MRI-verified approach. Journal of Neurology, Neurosurgey, and Psychiatry, 85(12), 1419-1425. doi: 10.1136/jnnp-2013-306907spa
dc.relation.referencesBailey, M., y Goldman, J. G. (2017). Characterizing cognitive impairment in Parkinson´s disease. Seminars in Neurology, 37(2), 167-175. doi: 10.1055/s-0037-1601894spa
dc.relation.referencesBaille, G., De Jesús, A. M., Pérez, T., Devos, D., Dujardin, K., Charley, C. M., … Morea, C. (2016). Ventilatory Dysfunction in Parkinson´s Disease. Journal of Parkinson´s Disease, 6(3), 463-471. doi: 10.3233/JPD-160804spa
dc.relation.referencesBejjani, B-P., Gervais, D., Arnulf, I., Papadopoulos, S., Demeret, S., Bonnet A-M., … Agid, Y. (2000). Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. Journal of Neurology, Neurosurgery & Psychiatry, 68(5), 595-600. doi: 10.1136/jnnp.68.5.595spa
dc.relation.referencesBhuta, T., Patrick, L., y Garnett, J. D. (2004). Perceptual evaluation of voice quality and its correlation with acoustic measurements. Journal of Voice, 18(3), 299-304. doi: 10.1016/j.jvoice.2003.12.004spa
dc.relation.referencesBlumin, J. H., Pcolinsky, D. E., & Atkins, J. P. (2004). Laryngeal findings in advanced Parkinson’s disease. Annals of Otology, Rhinology, and Laryngology, 113(4), 253–258. doi: 10.1177/000348940411300401spa
dc.relation.referencesBlumstein, S. E., y Baum, S. R. (2016). Neurobiology of Speech Production: Perspective from Neuropsychology and Neurolinguistics. En G. Hickok y S. L. Small (Eds.), Neurobiology of Language (pp. 689-699). Londres, Reino Unido: Academic Press.spa
dc.relation.referencesBoersma, P. (2001). Praat, a system for doing phonetics by computer. Glot International, 5(9-10), 341-345.spa
dc.relation.referencesBreit, S., Schulz, J. B., y Benabid, A-L. (2004). Deep brain stimulation. Cell and Tissue Research, 318(1), 275-288. doi: 10.1007/s00441-004-0936-0spa
dc.relation.referencesBocanegra, Y., Trujillo-Orrego. N., Pineda, D. (2014). Demencia y deterioro cognitivo leve en Enfermedad de Parkinson: una revisión. Revista de Neurología, 59(12), 555-569. doi: 10.33588/rn.5912.2014082spa
dc.relation.referencesBrown, K. A., y Spencer, K. A. (2020). The relationship between speech characteristics and motor subtypes of Parkinson´s disease. American Journal of Speech-Language Pathology, 29(4), 2145-2154. doi: 10.1044/2020_AJSLP-20-00058spa
dc.relation.referencesCaekebeke, J. F., Jennekens-Schinkel, A., Van der Linden, M. E., Buruma, O., y Roos, R. A. (1991). The interpretation of dysprosody in patients with Parkinson´s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 54(2), 145-148. doi: 10.1136/jnnp.54.2.145spa
dc.relation.referencesCavallieri, F., Brudriesi, C., Gessani, A., Contardi, S., Fioravanti, V., Menozzi, E., … Antonelli, F. (2021). Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients with Advanced Parkinson’s Disease. Frontiers in Neurology, 11, 616062. doi: 10.3389/fneur.2020.616062spa
dc.relation.referencesChiu, Y-F., y Neel, A. (2020). Predicting Intelligibility Deficits in Parkinson´s Disease with Perceptual Speech Ratings. Journal of Speech, Language, and Hearing Research, 63(2), 433-443. doi: 10.1044/2019_JSLHR-19-00134spa
dc.relation.referencesChou, K. L., Grube. S., y Patil, P. G. (2012). Deep Brain Stimulation: A New Life for People with Parkinson´s, Dystonia, and Essential Tremor. Nueva York, Estados Unidos: Demos Medical Publishing.spa
dc.relation.referencesCilia, R., Cereda, E., Akpalu, A., Sarfo, F. S., Cham, M., Laryea, V. O., … Pezzoli, G. (2020). Natural history of motor symptoms in Parkinson´s disease and the long-duration response to levodopa. Brain, 143(8), 2490-2501. doi: 10.1093/brain/awaa181spa
dc.relation.referencesClark, J. P., Adams, S. G., Dykstra, A. D., Moodie, S., y Jog, M. (2014). Loudness perception and speech intensity control in Parkinson's disease. Journal of Communication Disorders, 51(10), 1-12. doi: 10.1016/j.jcomdis.2014.08.001spa
dc.relation.referencesColton, C., Casper, K., y Leonard, R. (2006). Understanding voice problems: a physiological perspective for diagnosis and treatment (3ra ed.) Filadelfia, EE.UU: Lippincott Williams & Wilkins.spa
dc.relation.referencesD’Alatri, L., Paludetti, G., Contarino, F., Galla, S., Marchese M. R., y Bentivoglio A. R. (2006). Effects of Bilateral Subthalamic Nucleus Stimulation and Medication on Parkinsonian Speech Impairment. Journal of Voice, 22(3), 365-372. doi: 10.1016/j.jvoice.2006.10.010spa
dc.relation.referencesDarley, F., Aronson, A., y Brown, J. (1978). Trastornos Motrices del Habla. (I. Lorenzo, Trad.) Buenos Aires: Editorial Médica Panamericana.spa
dc.relation.referencesDashtipour, K., Tafreshi, A., Lee, J., y Crawley, B. (2018). Speech disorders in Parkinson's disease: pathophysiology, medical management, and surgical approaches. Neurodegenerative Disease Management, 8(5), 337-348. doi: 10.2217/nmt-2018-0021spa
dc.relation.referencesDastolfo-Hromack, C., Bush, A., Chrabaszcz, A., Alhourani, A., Lipski, W., Wang, D., … Richardson, R. M. (2022). Articulatory gain predicts motor cortex and subthalamic nucleus activity during speech. Cerebal Cortex, 32, 1337-1349. doi: 10.1093/cercor/bhab251spa
dc.relation.referencesDe Letter, M., Santens, P., De Bodt, M., Boon, P., y Van Borsel, J. (2006). Levodopa-induced alterations in speech rate in advanced Parkinson´s disease. Acta Neurologica Belgica, 106(1), 19-22.spa
dc.relation.referencesDe Letter, M., Santens, P., Estercam, I., Van Maele, G., De Bodt, M., Boon, P., y Van Borsel, J. (2007). Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson’s disease as perceived by professional listeners. Clinical Linguistics and Phonetics, 21(10), 783–791. doi: 10.1080/02699200701538181spa
dc.relation.referencesDe Letter, M., Santens, P., y Van Borsel, J. (2005). The effects of levodopa on word intelligibility in Parkinson’s disease. Journal of Communication Disorders, 38(3), 187–196. doi: 10.1016/j.jcomdis.2004.09.001spa
dc.relation.referencesDelgado, J., León, N. M., Jiménez, A., e Izquierdo, L. M. (2017). Análisis acústico de la voz: medidas temporales, espectrales y cepstrales en la voz normal con el Praat en una muestra de hablantes de español. Revista de Investigación en Logopedia, 7(2), 108-127.spa
dc.relation.referencesDromey, C., Kumar, R., Lang, A. E., y Lozano, A. M. (2000). An Investigation of the Effects of Subthalamic Nucleus Stimulation on Acoustic Measures of Voice. Movement Disorders, 15(6), 1132-1138.spa
dc.relation.referencesDuffy. J. R. (2005). Motor speech disorders: substrates, differential diagnosis, and management. Filadelfia, Estados Unidos: Elsevier Health Sciences.spa
dc.relation.referencesEklund, E., Qvist, J., Sandström, L., Viklund, F., van Doorn, J., y Karlsson, F. (2015). Perceived articulatory precision in patients with Parkinson’s disease after deep brain stimulation of subthalamic nucleus and caudal zona incerta. Clinical Linguistics & Phonetics, 29(2), 150-166. doi: 10.3109/02699206.2014.971192spa
dc.relation.referencesEstevo, A., Tonidandel, M., Papaterra, J. C., y Reis, E. (2016). Speech disorders did not correlate with age at onset of Parkinson´s disease. Arquivos de Neuro-Psiquiatria, 74(2), 117-122. doi: 10.1590/0004-282X20160008spa
dc.relation.referencesFabbri, M., Guimaraes, I., Cardoso, R., Coelho, M., Correia, L., Rosa, M. M., … Ferreira, J. J. (2017). Speech and Voice Response to Levodopa Challenge in Late-Stage Parkinson’s Disease. Frontiers in Neurology, 8, 432. doi: 10.3389/fneur.2017.00432spa
dc.relation.referencesForrest, K., Weismer, G., y Turner, G. S. (1989). Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults. The Journal of the Acoustical Society of America, 85(6), 2608-2622. doi: 10.1121/1.397755spa
dc.relation.referencesFrost, E., Tripoliti, E., Hariz, M., Pring, T., y Limousin, P. (2010). Self-perception of speech changes in patients with Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. International Journal of Speech-Language Pathology, 12(5), 399-404. doi: 10.3109/17549507.2010.497560spa
dc.relation.referencesGentil M., Pinto, S., Pollack, P., Benabid, A-L. (2003). Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain and Language, 85(2), 190-196. doi: 10.1016/s0093-934x(02)00590-4spa
dc.relation.referencesGetz, S. J., y Levin, B. (2017). Cognitive and neuropsychiatric features of early Parkinson's disease. Archives of Clinical Neuropsychology, 32(7),769-785. doi: 10.1093/arclin/acx091spa
dc.relation.referencesGorris, C., Ricci, A., Vanoni, F., Poggioli, M., Vaschetto, R., Garzaro, M., y Valletti, P. A. (2020). Acoustic Analysis of Normal Voice Patterns in Italian Adults by Using Praat. Journal of Voice, 34(6), 961.e9-961.e18. doi: 10.1016/j.jvoice.2019.04.016spa
dc.relation.referencesGrover, T., Georgiev, D., Kalliola, R., Mahlknecht, P. Zachaira, A., Candelario, J., … Tripoliti, E. (2019). Effect of Low versus High Frequency Subthalamic Deep Brain Stimulation on Speech Intelligibility and Verbal Fluency in Parkinson’s Disease: A Double-Blind Study. Journal of Parkinson´s Disease, 9(1), 141-151. doi: 10.3233/JPD-181368spa
dc.relation.referencesGuenther, F. (2007). Neuroimaging of Normal Speech Production. En R. J. Ingham (Ed.), Neuroimaging in Communication Sciences and Disorders (1-51). San Diego, Estados Unidos: Plural Publishing.spa
dc.relation.referencesGuenther, F., y Hickok, G. (2016). Neural Models of Speech Production. En G. Hickok y S. L. Small (Eds.), Neurobiology of Language (pp. 725-740). Londres, Reino Unido: Academic Press.spa
dc.relation.referencesHammer, M. J., y Barlow, S. M. (2010). Laryngeal somatosensory deficits in Parkinson’s disease: implications for speech respiratory and phonatory control. Experimental Brain Research, 201(3), 401-409. doi: 10.1007/s00221-009-2048-2spa
dc.relation.referencesHammer, M. J., Barlow, S. M., Lyons, K. E., y Pahwa, R. (2010). Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson's disease. Journal of Neurology, 257(10), 1692-1702. doi: 10.1007/s00415-010-5605-5spa
dc.relation.referencesHammer, M. J., Barlow, S. M., Lyons, K. E., y Pahwa, R. (2011). Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson’s disease. Journal of Communication Disorders, 44(1), 37-48. doi: 10.1016/j.jcomdis.2010.07.001spa
dc.relation.referencesHariz, M. I., Krack, P., Melvill, R., Jorgensen, J. V., Hamel, W., Hirabayashi, H., … Yousry, T. A. (2003). A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain electrodes. Stereotactic and Functional Neurosurgery, 80(1-4), 96-101. doi: 10.1159/000075167spa
dc.relation.referencesHartelius, L., y Svensson, P. (1994). Speech and swallowing symptoms associated with Parkinson´s Disease and Multiple Sclerosis: a survey. Folia Phoniatrica et Logopaedica, 46(1), 9-17. doi: 10.1159/000266286spa
dc.relation.referencesHartinger, M., Tripoliti, E., Hardcastle, W. J., y Limousin, P. (2011). Effects of medication and subthalamic nucleus deep brain stimulation on tongue movements in speakers with Parkinson’s disease using electropalatography: A pilot study. Clinical Linguistics & Phonetics, 25(3), 210-230. doi: 0.3109/02699206.2010.521877spa
dc.relation.referencesHawthorne, K., y Fischer, S. (2020). Speech-language pathologist and prosody: clinical practices and barriers. Journal of Communication Disorders, 87, 106024. doi: 10.1016/j.jcomdis.2020.106024spa
dc.relation.referencesHedge, M., y Freed, D. (2011). Assessment of communication disorders in adults. San Diego, EE.UU: Plural Publishing.spa
dc.relation.referencesHegland, K. W., Troche, M., y Brandimore, A. (2019). Relationship Between Respiratory Sensory Perception, Speech, and Swallow in Parkinson’s Disease. Movement Disorders, 6(3), 243-249. doi: 10.1002/mdc3.12732spa
dc.relation.referencesHoffman-Ruddy, B., Schulz, G., Vitek, L., y Evatt, M. (2001). A preliminary study of the effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on voice and speech characteristics in Parkinson’s Disease (PD). Clinical Linguistics & Phonetics, 15(1-2), 97-101. doi: 10.3109/02699200109167638spa
dc.relation.referencesHolmes, R. J., Oates, J. M., Phyland, D. J., y Hughes, A. J. (2000). Voice characteristics in the progression of Parkinson’s disease. International Journal of Language and Communication Disorders, 35(3), 407–418. doi: 10.1080/136828200410654spa
dc.relation.referencesHonda, K. (2015). Supralaryngeal Articulators in the Oropharyngeal Region. En M. A. Redford (Ed.), The Handbook of Speech Production (59-78). Oxford, Reino Unido: Wiley Blackwell.spa
dc.relation.referencesHosseinifar, S., Torabinezhad, F., Ghelichi, L., Roudbari, M., Pearson, E., y Faham, M. (2018). How Do Voice Perceptual Changes Predict Acoustic Parameters in Persian Voice Patients? Journal of Voice, 32(6), 705-709. doi: 10.1016/j.jvoice.2017.08.015spa
dc.relation.referencesHuber, J. E., Stathopoulos, E. T. (2015). Speech Breathing Across the Life Span and in Disease. En M. A. Redford (Ed.), The Handbook of Speech Production (13-33). Oxford, Reino Unido: Wiley Blackwell.spa
dc.relation.referencesHunker, C., Abbs, J., y Barlow, S. (1982). The relationship between parkinsonian rigidity and hypokinesia in the orofacial system: a quantitative analysis. Neurology,32(7), 749-754. doi: 10.1212/wnl.32.7.749spa
dc.relation.referencesIcht, M., y Ben-David, B. M. (2018). Evidence-Based Clinical Recommendations for the Administration of the Sequential Motion Rates Task. Communication Disorders Quarterly, 39(3), 442-448. doi: 10.1177/1525740117713165spa
dc.relation.referencesIm, H., Adams, S., Abeyesekera, A., Pieterman, M., Gilmore, G., y Jog, M. (2018). Effect of levodopa on speech dysfluency in Parkinson’s disease. Movement Disorders, 6(2), 150-154. doi: 10.1002/mdc3.12714spa
dc.relation.referencesJost, W. H. (2017). Autonomic dysfunction in Parkinson's disease: cardiovascular symptoms, thermoregulation, and urogenital symptoms. International Review of Neurobiology, 134, 771-785. doi: 10.1016/bs.irn.2017.04.003spa
dc.relation.referencesKalia, L. V., y Kalia, S. K. (2015). a-Synuclein and Lewy pathology in Parkinson's disease. Current Opinion in Neurology, 28(4), 375-381. doi: 10.1002/ana.23746spa
dc.relation.referencesKalia, L. V., Kalia, S. K., McLean., P. J., Lozano A. M., y Lang, A. E. (2013). a-Synuclein oligomers and clinical implications for Parkinson disease. Annals of Neurology, 73(2), 155-169. doi: 10.1002/ana.23746spa
dc.relation.referencesKalia, L. V., y Lang, A. E. (2015). Parkinson's disease. Lancet, 386(9996), 896-912. doi: 10.1016/S0140-6736(14)61393-3spa
dc.relation.referencesKarlsson, F., Malinova, E., Olofsson, K., Blomstedt, P., Linder J., y Nordh, E. (2019). Voice Tremor Outcomes of Subthalamic Nucleus and Zona Incerta Deep Brain Stimulation in Patients with Parkinson Disease. Journal of Voice, 33(4), 545-549. doi: 10.1016/j.jvoice.2017.12.012spa
dc.relation.referencesKarlsson, F., Olofsson, K., Blomstedt, P., Linder, J., y van Doorn, J. (2013). Pitch Variability in Patients with Parkinson’s Disease: Effects of Deep Brain Stimulation of Caudal Zona Incerta and Subthalamic Nucleus. Journal of Speech, Language, and Hearing Research, 56(1), 150-158. doi: 10.1044/1092-4388(2012/11-0333)spa
dc.relation.referencesKarlsson, F., Unger, E., Wahlgren, S., Blomstedt, P., Linder, J., Nordh, E., … van Doorn, J. (2011). Deep Brain Stimulation of Caudal Zona Incerta and Subthalamic Nucleus in Patients with Parkinson’s Disease: Effects on Diadochokinetic Rate. Parkinson´s Disease, 605607. doi:10.4061/2011/605607spa
dc.relation.referencesKogan, M., McGuire, M., y Riley, J. (2019). Deep Brain Stimulation for Parkinson Disease. Neurosurgery Clinics of North America, 30(2). doi: 10.1016/j.nec.2019.01.001spa
dc.relation.referencesKojovic, M., Mir, P., Trender-Gerhard, I., Schneider, S. A., Pareés, I., Edwards, M. J., … Jahanshahi, M. (2014). Motivational modulation of bradykinesia in Parkinson´s disease off and on dopaminergic medication. Journal of Neurology, 261, 1080-1089. doi: 10.1007/s00415-014-7315-xspa
dc.relation.referencesKlostermann, F., Ehlen, F., Vesper, J., Nubel, K., Gross, M., Marzinzik, F., … Sappok, T. (2008). Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 79(5), 522-529, doi: 10.1136/jnnp.2007.123323spa
dc.relation.referencesKnowles, T., Adams, S., Abeyesekera, A., Mancinelli, C., Gilmore, G., y Jog, M. (2018). Deep Brain Stimulation of the Subthalamic Nucleus Parameter Optimization for Vowel Acoustics and Speech Intelligibility in Parkinson’s Disease. Journal of Speech, Language, and Hearing Research, 61(3), 510-524. doi: 10.1044/2017_JSLHR-S-17-0157spa
dc.relation.referencesKummer, A. W. (2014). Speech Evaluation for Patients with Cleft Palate. Clinics in Plastic Surgery, 41(2), 241-251. doi: 10.1016/j.cps.2013.12.004spa
dc.relation.referencesLaPointe, L. L., Murdoch, B. E., y Stierwalt, J. A. G. (2010). Brain-Based Communication Disorders. San Diego, Estados Unidos: Plural Publishing.spa
dc.relation.referencesLee, V. S., Zhou, X. P., Rahn III, D. A., Wang, E. Q., y Jiang, J. J. (2008). Perturbation and nonlinear dynamic analysis of acoustic phonatory signal in Parkinsonian patients receiving deep brain stimulation. Journal of Communication Disorders, 41(6), 485-500. doi: 10.1016/j.jcomdis.2008.02.001spa
dc.relation.referencesLe Huche, F., y Allali, A. (2004). La voz. Tomo I: anatomía y fisiología de los órganos de la voz y el habla. Madrid, España: Masson S.A.spa
dc.relation.referencesLevy, G., Tang, M. X., Cote, L, J., Louis, E. D., Alfaro, B., Mejia, H., … Marder, K. (2000). Motor impairment in PD: relationship to incident dementia and age. Neurology, 55(4). doi: 10.1212/wnl.55.4.539spa
dc.relation.referencesLeWitt, P. A., y Fahn, S. (2016). Levodopa therapy for Parkinson disease a look backward and forward. Neurology, 86(supl 1), S3-S12. doi: 10.1212/WNL.0000000000002509spa
dc.relation.referencesLipski, W., Alhourani, A., Pirnia, T., Jones, P. W., Dastolfo-Hromack, C., Helou, L. B., … Richardson, R. M. (2018). Subthalamic nucleus neurons differentially encode early and late aspects of speech production. The Journal of Neuroscience, 38(24), 5620-5631. doi: 10.1523/jneurosci.3480-17.2018spa
dc.relation.referencesLundgren, S., Saeys, T., Karlsson, F., Olofsson, K., Blomstedt, P., Linder, J., … van Doorn, J. (2011). Deep Brain Stimulation of Caudal Zona Incerta and Subthalamic Nucleus in Patients with Parkinson’s Disease: Effects on Voice Intensity. Parkinson´s Disease, 658956. doi: 10.4061/2011/658956spa
dc.relation.referencesMa, J. K. Y., Schneider, C. B., Hoffmann, R., y Storch, A. (2015). Speech Prosody Across Stimulus Types for Individuals with Parkinson’s Disease. Journal of Parkinson´s Disease, 5(2), 291-299. doi: 10.3233/JPD-140451spa
dc.relation.referencesMajdinasab, F., Karkheiran, S., Soltani, M., Moradi, N., y Shahidi, G. (2016). Relationship between voice and motor disabilities of Parkinson´s Disease. Journal of Voice, 30(60), 768.e17-768.e22. doi: 10.1016/j.jvoice.2015.10.022spa
dc.relation.referencesMalek, N. (2019). Deep Brain Stimulation in Parkinson’s Disease. Neurology India, 67(4), 968-978. doi: 10.4103/0028-3886.266268spa
dc.relation.referencesMartel-Sauvageau, V., Marcöir, J., Langlois, M., Prud´Homme, M., Cantarin, L., y Roy J. P. (2014). Changes in vowel articulation with subthalamic nucleus deep brain stimulation in dysarthric speakers with Parkinson's disease. Parkinson´s Disease, 407035. doi: 10.1155/2014/487035spa
dc.relation.referencesMartínez, A., Felizzola, C. A., Matallana, D. L. (2015). Valoración de la prosodia espontánea afectiva y análisis del discurso en participantes con esquizofrenia y demencia frontotemporal (DFT) variante lingüística. Revista Colombiana de Psiquiatría, 44(1), 13-19. doi: 10.1016/j.rcp.2015.01.003spa
dc.relation.referencesMhyre, T. R., Boyd, J. T., Hamill, R. W., y Maguire-Zeiss, K. A. (2012). Parkinson´s Disease. Sub-cellular Biochemistry, 65, 389-455. doi: 10.1007/978-94-007-5416-4_16spa
dc.relation.referencesMidi, I., Dogan, M., Koseoglu, M., Can, G., Sehitoglu, M. A., y Gunal, D. I. (2008). Voice abnormalities and their relation with motor dysfunction in Parkinson´s Disease. Acta Neurologica Scandinavica, 117(1), 26–34. doi: 10.1111/j.1600-0404.2007.00965.xspa
dc.relation.referencesMiocinovic, S., Somayajula, S., Chitnis, S., y Vitek, J. L. (2012). History, applications, and mechanisms of deep brain stimulation. JAMA Neurology, 70(2), 163-171. doi: 10.1001/2013.jamaneurol.45spa
dc.relation.referencesMoreau, C., Pennel-Ployart, O., Pinto, S., Plachez, A., Anninc, A., Viallet, F., … Defebvre, L. (2011). Modulation of Dysarthropneumophonia by Low-Frequency STN DBS in Advanced Parkinson’s Disease. Movement Disorders, 26(4), 659-663. doi: 10.1002/mds.23538spa
dc.relation.referencesMorello, A., Costa, B., Carvalho, V., Aparecida, y C., Rieder, C. (2020). Dysphonia and Dysarthria in People with Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation. Journal of Voice, 34(3), 477-484. doi: 10.1016/j.jvoice.2018.10.012spa
dc.relation.referencesMotta, S., Cesari, U., Paternoster, M., Motta, G. y Orefice, G. (2018). Aerodynamic findings and Voice Handicap Index in Parkinson’s disease. European Archives of Oto-Rhino-Laryngology, 275(6), 1569-1577. doi: 10.1007/s00405-018-4967-7spa
dc.relation.referencesMoya-Galé, G., Goudarzi, A., Bayés, Á., McAuliffe, Bulté, B., y Levy, E. S. (2018). The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers with Parkinson´s Disease. American Journal of Speech-Language Pathology, 27(1), 154-165. doi: 10.1044/2017_AJSLP-17-0032spa
dc.relation.referencesMurdoch, B. (2010). Surgical approaches to treatment of Parkinson`s disease: implications for speech function. International Journal of Speech-Language Pathology, 12(5),375–389.spa
dc.relation.referencesNachev, P., Kennard, C., y Husain, M. (2008). Functional role of the supplementary and pre-supplementary motor areas. Nature Reviews Neuroscience, 9, 856-869. doi: 10.1038/nrn2478spa
dc.relation.referencesNeel, A. (2009). Effects of Loud and Amplified Speech on Sentence and Word Intelligibility in Parkinson Disease. Journal of Speech, Language and, Hearing Research, 52(4), 1021-1033. doi: 10.1044/1092-4388(2008/08-0119)spa
dc.relation.referencesOkun, M. S. (2012). Deep-brain stimulation for Parkinson’s disease. The New England Journal of Medicine, 367(16), 1529-1538. doi: 10.1056/NEJMct1208070spa
dc.relation.referencesOliveira, R. C., Gama, A. C., y Magalhaes, M. D. (2021). Fundamental Voice Frequency: Acoustic, Electroglottographic, and Acelerometer Measurement in Individuals with and without Vocal Alteration. Journal of Voice, 35(2), 174-180. doi: 10.1016/j.jvoice.2019.08.004spa
dc.relation.referencesOrtega-García, J., González-Rodríguez, J., y Marrero-Aguiar, V. (2000). AHUMADA: A large speech corpus in Spanish for speaker characterization and identification. Speech Communication, 31(2-3), 255-264. doi: 10.1016/S0167-6393(99)00081-3spa
dc.relation.referencesPereira, G., Cervantes, O., Abrahao, M., Parente, F. A., y Carrara, E. (2002). Noise-to-Harmonics Ratio as an Acoustic Measure of Voice Disorders in Boys. Journal of Voice, 16(1), 28-31.spa
dc.relation.referencesPhokaewvarangkul, O., Kamolwan, B., y Bhidayasiri, R. (2019). Subthalamic deep brain stimulation aggravates speech problems in Parkinson's disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location. Parkinsonism and Related Disorders, 66, 110-116. doi: 10.1016/j.parkreldis.2019.07.020spa
dc.relation.referencesPierce, J. E., Cotton, S., y Perry, A. (2013). Alternating and sequential motion rates in older adults. International Journal of Language & Communication Disorders, 48(3), 257-264. doi: 10.1111/1460-6984.12001spa
dc.relation.referencesPinto, S., Gentil, M., Fraix, V., Benabid, A-L., y Pollack, P. (2003). Bilateral subthalamic stimulation effects on oral force control in Parkinson’s disease. Journal of Neurology, 250(2), 179-187. doi: 10.1007/s00415-003-0966-7spa
dc.relation.referencesR Core Team. (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.spa
dc.relation.referencesRedgrave, P. (2007). Basal ganglia. doi:10.4249/scholarpedia.1825spa
dc.relation.referencesReich, S. G., y Savitt, J. M. (2019). Parkinson Disease. The Medical Clinics of North America, 103(2), 337-350. doi: 10.1016/j.mcna.2018.10.014spa
dc.relation.referencesRobertson, L. T., St George, R. J., Carlson-Kuhta, P., Hogarth, P., Burchiel, K. J., y Horak, F. B. (2011). Site of Deep Brain Stimulation and Jaw Velocity in Parkinson’s Disease. Journal of Neurosurgery, 115(5), 985-994. doi: 10.3171/2011.7.JNS102173spa
dc.relation.referencesRomann, A. J., Costa, B., Aparecida, C., y de Mello-Rieder, C. R. (2019). Acoustic Voice Modifications in Individuals with Parkinson Disease Submitted to Deep Brain Stimulation. International Archives of Otorhinolaryngology, 23(2), 203-208. doi: 10.1055/s-0038-1675392spa
dc.relation.referencesRoth, F., y Worthington, C. K. (2001). Treatment Resource Manual for Speech-Language Pathology. Albany, EE. UU.: Singular Publishing.spa
dc.relation.referencesRousseaux, M., Krystkowiak, P., Kozlowsky, O., Özsancak C., Blond, S., y Destée, A. (2004). Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility. Journal of Neurology, 251(3), 327-334. doi: 10.1007/s00415-004-0327-1spa
dc.relation.referencesRusz, J., y Tykalová, T. (2020). Does cognitive impairment influence motor speech performance in De Novo Parkinson’s disease? Movement Disorders, 36(12), 2980-2982. doi: 10.1002/mds.28836spa
dc.relation.referencesSalgado, A. (2007). Manual práctico de tartamudez. Madrid, España: Editorial Síntesis.spa
dc.relation.referencesSanabria, J., Ruiz, P. G., Gutierrez, R., Márquez, F., Escobar, P., Gentil, M., y Cenjor C. (2001). The effect of levodopa on vocal function in Parkinson´s disease. Clinical Neuropharmacology, 24(2). 99-102. doi: 10.1097/00002826-200103000-00006spa
dc.relation.referencesSapir, S., Ramig, L. O., Spielman, J. L., y Fox, C. (2010). Formant Centralization Ratio (FCR): A proposal for a new acoustic measure of dysarthric speech. Journal of Speech, Language, and Hearing Research, 53(1), 114-125. doi: 10.1044/1092-4388(2009/08-0184)spa
dc.relation.referencesSarac, E. T., Yilmaz, A., Aydinli, F. E., Yildizgoren, M. T., Okuyucu, E. E., Okuyucu, S., y Akakin, A. (2020). Investigating the effects of subthalamic nucleus-deep brain stimulation on the voice quality. Somatosensory & Motor Research, 37(3), 157-164. doi: 10.1080/08990220.2020.1761317spa
dc.relation.referencesSchuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., … y Deuschl, G. (2013). Neurostimulation for Parkinson's disease with early motor complications. New England Journal of Medicine, 368(7), 610-622. doi: 10.1056/NEJMoa1205158spa
dc.relation.referencesShipley, K., y McAfee, J. (1998). Assessment in speech-language pathology: a resource manual. Nueva York: Delmar Cenage Learning.spa
dc.relation.referencesSilbergleit A. K., LeWitt, P. A., Peterson, E. L., y Gardner, G. M. (2015). Quantitative Analysis of Voice in Parkinson Disease Compared to Motor Performance: A Pilot Study. Journal of Parkinson´s Disease, 5(3), 517-524. doi: 10.3233/JPD-140526spa
dc.relation.referencesSkodda, S. (2010). Speech and voice disorders in Parkinson´s disease. En A. E. Harrison (Ed.), Speech Disorders: Causes, Treatment and Social Effects (pp. 1-41). Londres, Reino Unido: Nova Science Publishers.spa
dc.relation.referencesSkodda, S. (2012). Effect of deep brain stimulation on speech performance in Parkinson’s disease. Parkinson’s Disease, 2012, 850596. doi: 10.1155/2012/850596spa
dc.relation.referencesSkodda, S., Visser, W., y Schlegel. (2011). Vowel articulation in Parkinson´s Disease. Journal of Voice, 25(4), 467-472. doi: 10.1016/j.jvoice.2010.01.009spa
dc.relation.referencesSmith, L. K., y Goberman, A. M. (2014). Long-time average spectrum in individuals with Parkinson disease. NeuroRehabilitation, 35(1), 77-88. doi: 10.3233/NRE-141102spa
dc.relation.referencesSpeyer, R., Bogaardt, H. C. A., Lima, V., Roodenburg, N., Zumach, A., Heijnen, M., Baijens, L., … Brunings, J. W. (2010). Maximum Phonation Time: Variability and Reliability. Journal of Voice, 24(3), 281-284. doi: 10.1016/j.jvoice.2008.10.004spa
dc.relation.referencesSpindola, B., Leite, M. A., Orsini, M., Fonoff, E., Landeiro, J. A., y Pessoa B. L. (2017). Ablative surgery for Parkinson's disease: is there still a role for pallidotomy in the deep brain stimulation era? Clinical Neurology and Neurosurgery, 158, 33-39. doi: 10.1016/j.clineuro.2017.04.018spa
dc.relation.referencesStegemöller, E. L. (2017). The neuroscience of speech and language. Music Therapy Perspectives, 35(2), 107-112. doi: 10.1093/mtp/mix007spa
dc.relation.referencesStory, B. H. (2015). Mechanisms of Voice Production. En M. A. Redford (Ed.), The Handbook of Speech Production (34-58). Oxford, Reino Unido: Wiley Blackwell.spa
dc.relation.referencesTakafumi, T., Kajita, Y., Kaneoke, Y., Takebayashi, S., Nakatsubo, D., y Wakabayashi, T. (2009). Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson´s disease. Acta Neurochirurgica, 151(6), 589-594. doi: 10.1007/s00701-009-0293-6spa
dc.relation.referencesTanaka, Y., Tsuboi, T., Watanabe, H., Kajita, Y., Natakatsubo, D., Fujimoto, Y., … Sobue, G. (2016). Articulation Features of Parkinson’s Disease Patients with Subthalamic Nucleus Deep Brain Stimulation. Journal of Parkinson´s Disease, 6(4), 811-819. doi: 10.3233/JPD-160838spa
dc.relation.referencesTanaka, Y., Tsuboi, T., Watanabe, H., Kajita, Y., Fujimoto, Y., Ohdake, R., … Sobue, G. (2015). Voice features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. Journal of Neurology, 262(5), 1173-1181. doi: 10.1007/s00415-015-7681-zspa
dc.relation.referencesTanaka, Y., Tsuboi, T., Watanabe, H., Natakatsubo, D., Maesawa, S., Kato, S … Sobue, G. (2020). Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study. Journal of Parkinson´s Disease, 10(1), 131-140. doi: 10.3233/JPD-191798spa
dc.relation.referencesTeixeira, J. P., y Fernandes, P. O. (2014). Jitter, Shimmer and HNR Classification within Gender, Tones and Vowels in Healthy Voices. Procedia Technology, 16, 1228-1237. doi: 10.1016/j.protcy.2014.10.138spa
dc.relation.referencesTheodoros, D. (2011). Speech Disorder in Parkinson’s Disease. En D. Theodoros y L. Ramig (Eds.), Communication and swallowing in Parkinson´s Disease (pp. 51-88). San Diego, Estados Unidos: Plural Publishing.spa
dc.relation.referencesTremblay, P., Deschamps, I., y Gracco, V. L. (2016). Neurobiology of Speech Production: a Motor Control Perspective. En G. Hickok y S. L. Small (Eds.), Neurobiology of Language (pp. 741-750). Londres, Reino Unido: Academic Press.spa
dc.relation.referencesTripoliti, E., Limousin, P., Foltynie, T., Candelario, J., Aviles-Olmos, I., Hariz. M y Zrinzo, L. (2014). Predictive Factors of Speech Intelligibility Following Subthalamic Nucleus Stimulation in Consecutive Patients with Parkinson’s Disease. Movement Disorders, 29(4), 532-538. doi: 10.1002/mds.25816spa
dc.relation.referencesTripoliti, E., Limousin, P., Tisch, S., Borrell, E., y Hariz, M. I. (2006). Speech in Parkinson's disease following subthalamic nucleus deep brain stimulation: preliminary results. Journal of Medical Speech Language Pathology, 14(1), 309-315.spa
dc.relation.referencesTripoliti, E., Zrinzo, L., Martínez-Torres, I., Frost, E., Pinto, S., Foltynie, T., … Limousin, P. (2011). Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology, 76(1), 80-86. doi: 10.1212/WNL.0b013e318203e7d0spa
dc.relation.referencesTripoliti, E., Zrinzo, L., Martínez-Torres, I., Tisch, S., Frost, E. Borrell, E., … Limousin, P. (2008). Effects of Contact Location and Voltage Amplitude on Speech and Movement in Bilateral Subthalamic Nucleus Deep Brain Stimulation. Movement Disorders, 23(16), 2377-2383. doi: 10.1002/mds.22296spa
dc.relation.referencesTsuboi T., Watanabe, H., Tanaka, Y., Ohdake, R., Yoneyama, N., Hara, K., … Sobue, G. (2015a). Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation. Journal of Neurology, Neurosurgery, and Psychiatry, 86(8), 856-864. doi: 10.1136/jnnp-2014-308043spa
dc.relation.referencesTsuboi T., Watanabe, H., Tanaka, Y., Ohdake, R., Yoneyama, N., Hara, K., … Sobue, G. (2015b). Characteristic laryngoscopic findings in Parkinson’s disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder. Journal of Neural Transmission, 122(12), 1663-1672. doi: 10.1007/s00702-015-1436-yspa
dc.relation.referencesTsuboi, T., Watanabe, H., Tanaka, Y., Ohdake, R., Hattori, M., Kawabata, K., … Sobue, G. (2017). Early detection of speech and voice disorders in Parkinson’s disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study. Journal of Neural Transmission, 124(12), 1547-1559. doi: 10.1007/s00702-017-1804-xspa
dc.relation.referencesTykalová, T., Rusz, J., Cmejla, R., Klempír, J., Ruzicková, H., Roth, J. y Ruzicka, E. (2015). Effect of dopaminergic medication on speech dysfluency in Parkinson´s disease: a longitudinal study. Journal of Neural Transmission, 122(8), 1135-1142. doi: 10.1007/s00702-015-1363-yspa
dc.relation.referencesVaillancourt, D.E., Prodoehl, J., Metman, L.V., Bakay, R.A., y Crocos, D. M. (2004). Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson’s disease. Brain, 127(Pt 3), 491–504. doi: 10.1093/brain/awh057spa
dc.relation.referencesValálik, I., Smehák, G., Bognár, L., y Csókay, A. (2011). Voice acoustic changes during bilateral subthalamic stimulation in patients with Parkinson’s disease. Clinical Neurology and Neurosurgery, 113(3), 188-195. doi: 10.1016/j.clineuro.2010.11.002spa
dc.relation.referencesVandana, V. P., Darshini, J. K., Vikram, V. H., Nitish, K., Kumar, P. P., y Ravi, Y. (2021). Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role? Journal of Neurosciences in Rural Practice, 12(4), 673-679. doi: 10.1055/s-0041-1735249spa
dc.relation.referencesVaz, S., Melo, P., Almeida, V., y Ferreira, A. (2015). Integrating Voice Evaluation: Correlation Between Acoustic and Audio-Perceptual Measures. Journal of Voice, 29(3). doi: 10.1016/j.jvoice.2014.08.007spa
dc.relation.referencesVolkmann, J. (2004). Deep brain stimulation for the treatment of Parkinson's disease. Journal of Clinical Neurophysiology, 21(1), 6-17. doi: 10.1097/00004691-200401000-00003.spa
dc.relation.referencesWakabayashi, K., Tanji, K., Odagiri, S., Miki, y., Mori., F., y Takahashi, H. (2013). The Lewy body in Parkinson's disease and related neurodegenerative disorders. Molecular Neurobiology, 47(2), 495-508. doi: 10.1007/s12035-012-8280-yspa
dc.relation.referencesWang, E. Q., Metman, L. V. Bakay, R.A., Arzbaecher., Bernard, B., y Corcos, D. M. (2006). Hemisphere-specific effects of subthalamic nucleus deep brain stimulation on speaking rate and accuracy of syllable repetitions in Parkinson´s disease. Journal of Medical Speech-Language Pathology, 14(4), 323-334.spa
dc.relation.referencesWatkins, K. E., y Jenkinson, N. (2016). The Anatomy of Basal Ganglia. En G. Hickok y S. L. Small (Eds.), Neurobiology of Language (pp. 85-94). Londres, Reino Unido: Academic Press.spa
dc.relation.referencesWertheimer, J., Gottuso, A. Y., Nuno, M., Walton, C., Duboille, A., Tuchman, M., y Raming, L. (2014). The impact of STN deep brain stimulation on speech in individuals with Parkinson's disease: The patient's perspective. Parkinsonism and Related Disorders, 20(10), 1065-1070. doi: 10.1016/j.parkreldis.2014.06.010spa
dc.relation.referencesWest, J. B. (2003). Fisiología Respiratoria. Buenos Aires, Argentina: Editorial Médica Panamericana.spa
dc.relation.referencesXie, Y., Zhang, Y., Zheng, Z., Liu, A., Wang, X., Zhuang, P., … Wang, X. (2011). Changes in Speech Characters of Patients With Parkinson’s Disease After Bilateral Subthalamic Nucleus Stimulation. Journal of Voice, 25(6), 751-758. doi: 10.1016/j.jvoice.2010.08.002spa
dc.relation.referencesYiu, E. (2011). Maximum phonation performance. En E. Ma y E. Yui (Eds), Handbook of voice assessments (pp. 101-107). San Diego, EE.UU: Plural Publishing.spa
dc.relation.referencesZhou. X. P., Lee, V. S., Wang, E. Q., y Jiang, J. J. (2009). Evaluation of the effects of deep brain stimulation of the subthalamic nucleus and levodopa treatment on Parkinsonian voice using perturbation, nonlinear dynamic, and perceptual analysis. Folia Phoniatrica et Logopaedica, 61(4), 189-199. doi: 10.1159/000227996spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/spa
dc.subject.ddc610 - Medicina y saludspa
dc.subject.ddc410 - Lingüísticaspa
dc.subject.lembNeurocirugíaspa
dc.subject.lembNeurosurgeryeng
dc.subject.lembEnfermedades cerebralesspa
dc.subject.lembBrain - Diseaseseng
dc.subject.proposalParkinson´s diseaseeng
dc.subject.proposaldeep brain stimulationeng
dc.subject.proposaldysarthriaeng
dc.subject.proposalvoiceeng
dc.subject.proposalenfermedad de Parkinsonspa
dc.subject.proposalestimulación cerebral profundaspa
dc.subject.proposaldisartriaspa
dc.subject.proposalvozspa
dc.titleEl habla de personas con enfermedad de Parkinson tras una neurocirugía: seguimiento de pacientes hispanohablantes en Bogotá durante un añospa
dc.title.translatedSpeech outcome of people with Parkinson´s disease after a neurosurgery: one-year follow-up of Spanish-speaking patients in Bogotáeng
dc.typeTrabajo de grado - Maestríaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentEstudiantesspa
dcterms.audience.professionaldevelopmentInvestigadoresspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
1018474615.2022.pdf
Tamaño:
7.79 MB
Formato:
Adobe Portable Document Format
Descripción:
Tesis de Maestría en Neurociencias
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
5.74 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Maestría en Neurociencias